Position history for BAKER BROS. ADVISORS LP's holdings in NURIX THERAPEUTICS INC
BAKER BROS. ADVISORS LP holds 4.7M shares of NRIX (NURIX THERAPEUTICS INC), worth $88.4M as of 2025-Q4. The position was increased (++20.0% shares). NRIX represents 0.5% of BAKER BROS. ADVISORS LP's portfolio.
Current Value
$88.4M
Current Shares
4.7M
Total Value Change
+$7.4M
Total Shares Change
+776,431
Other major holders of NRIX: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 4.7M |
+20.0% |
| $88.4M |
| 0.5% |
| $19.02 |
50 |
| 2025-Q3 | Unchanged | 3.9M | 0.0% | $35.9M | 0.3% | $9.28 | 0 |
| 2025-Q2 | Unchanged | 3.9M | 0.0% | $44.2M | 0.4% | $11.64 | 0 |
| 2025-Q1 | Unchanged | 3.9M | 0.0% | $46.1M | 0.5% | $12.15 | 0 |
| 2024-Q4 | Unchanged | 3.9M | 0.0% | $73.1M | 0.8% | $18.64 | 0 |
| 2024-Q3 | Unchanged | 3.9M | 0.0% | $87.2M | 0.9% | $23.05 | 0 |
| 2024-Q2 | Unchanged | 3.9M | 0.0% | $81M | 1.0% | $20.87 | 0 |